Humoral and cellular immune response in kidney transplant recipients after COVID-19 vaccination
-
Published:2023-07-18
Issue:2
Volume:10
Page:47-48
-
ISSN:2373-6453
-
Container-title:Journal of Human Virology & Retrovirology
-
language:
-
Short-container-title:JHVRV
Author:
Cheepsattayakorn AttaponORCID,
Cheepsattayakorn Ruangrong,
Siriwanarangsun Porntep
Publisher
MedCrave Group Kft.
Reference14 articles.
1. Rincvon-Arevalo H, Choi M, Stefanski AL, et al. Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients. Sci Immunol. 2021;6 (60):eabj1031.
2. Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients : a prospective, multicenter observational study using mRNA 1273 or BNT162b2 mRNA vaccine;Stumpf;Lancet Reg Health Eur,2021
3. Chen JJ, Lee TH, Tian YC, et al. Immunogenicity rates after SARS-CoV-2 vaccination in people with end-stage kidney disease : a systematic review and meta-analysis. JAMA Netw Open. 2021;4(10): e2131749.
4. Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on hemodialysis;Strengert;eBioMedicine,2021
5. Equivalent humoral and cellular immune response but different side effect rates following SARS-CoV-2 vaccination in peritoneal and hemodialysis patients using messenger RNA;Stumpf;Nephrol Dial Transpl,2022